Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol

por Yeu, Rui Qian, Brandon, Rebecca, Jiang, Yannan, Griffiths, Dale, Smallman, Kate, Moffitt, Allan, Doherty, Glenn, Paul, Ryan, Harré Hindmarsh, Jennie, Merriman, Tony R, Macaskill-Smith, Kerry, Orr-Walker, Brandon, Murphy, Rinki
Publicado 2020

Health equity in the New Zealand health care system: a national survey

por Sheridan, Nicolette F, Kenealy, Timothy W, Connolly, Martin J, Mahony, Faith, Barber, P Alan, Boyd, Mary Anne, Carswell, Peter, Clinton, Janet, Devlin, Gerard, Doughty, Robert, Dyall, Lorna, Kerse, Ngaire, Kolbe, John, Lawrenson, Ross, Moffitt, Allan
Publicado 2011

Stratified glucose-lowering response to vildagliptin and pioglitazone by obesity and hypertriglyceridemia in a randomized crossover trial

por Brandon, Rebecca, Jiang, Yannan, Yeu, Rui Qian, Tweedie-Cullen, Ry, Smallman, Kate, Doherty, Glenn, Macaskill-Smith, Kerry A., Doran, Rebekah J., Clark, Penny, Moffitt, Allan, Merry, Troy, Nehren, Norma, King, Frances, Hindmarsh, Jennie Harré, Leask, Megan Patricia, Merriman, Tony R., Orr-Walker, Brandon, Shepherd, Peter R., Paul, Ryan, Murphy, Rinki
Publicado 2023